LUX Infusion通过 Qfitlia（fitusiran）扩大血友病治疗的可及性-动脉网

LUX Infusion Expands Access to Hemophilia Care with Qfitlia (fitusiran)

CISION 等信源发布 2026-10-09 22:37



可切换为仅中文







LUX Infusion is currently authorized to dispense Qfitlia, expanding access to a unique bleeding disorder treatment option.

LUX Infusion 目前已获准配发 Qfitlia，从而扩大了一种独特的出血性疾病治疗方案的可及性。

PLANTATION, Fla.

佛罗里达州普兰泰申

，

Oct. 9, 2026

2026年10月9日

/PRNewswire/ -- LUX Infusion (the 'Company'), a clinician-led infusion service network, today announced the availability of Qfitlia (fitusiran), which will not only broaden treatment access, but also clinical support for patients living with hemophilia A or B.

/美通社/ -- 由临床医生主导的输液服务网络 LUX Infusion（以下简称“公司”）今日宣布，Qfitlia（fitusiran）现已上市，这将不仅扩大治疗可及性，还为血友病 A 或 B 患者提供更全面的临床支持。

For patients 12 years and older with hemophilia A or B with or without Factor VIII or IX inhibitors that require routine bleed prevention treatment, Qfitlia is a subcutaneous treatment option. LUX Infusion is integrating the therapy into a care framework purpose-built to eliminate access barriers for patients..

对于12岁及以上、患有A型或B型血友病（无论是否存在VIII因子或IX因子抑制物）且需要常规出血预防治疗的患者，Qfitlia是一种皮下注射治疗选择。LUX Infusion正在将该疗法整合到一个专为消除患者获取障碍而设计的护理框架中。

'Making care easier to not only access, but also navigate is central to our mission,' said Ted Kramm, Chief Executive Officer of LUX Infusion. 'We hold a deep, long-standing commitment to the bleeding disorder community, and adding Qfitlia to our portfolio enables us to offer a unique treatment option that is fully supported by our high-touch model.'.

“让患者不仅更容易获得护理，还能更顺畅地应对整个诊疗过程，是我们使命的核心。”LUX Infusion 首席执行官泰德·克拉姆表示，“我们对出血性疾病社群有着深厚且长期的承诺，将 Qfitlia 纳入我们的产品组合，使我们能够提供一种独特的治疗选择，并由我们的高触感服务模式提供全面支持。”

Comprehensive Support for Hemophilia Patients

血友病患者的全面支持

Whether starting Qfitlia as a new patient or transitioning as an established patient to LUX Infusion, patients receive support throughout the treatment process. This means LUX Infusion not only helps patients navigate the initial barriers to treatment with a benefit and appeals team but also provides assistance to patients at every step of the day-to-day treatment journey..

无论是作为新患者开始使用Qfitlia，还是作为已在接受治疗的患者转至LUX Infusion，患者在整个治疗过程中都会获得支持。这意味着LUX Infusion不仅通过福利与申诉团队帮助患者克服治疗初期的障碍，还在日常治疗的每一步为患者提供支持。

The Company's bleeding disorder program is uniquely designed to work closely with patients and their Hemophilia Treatment Centers (HTCs), pairing every patient with a single point of contact that has real-world bleeding disorder experience, backed by 24/7 on-call guidance.

公司的出血性疾病项目独具特色，旨在与患者及其血友病治疗中心（HTCs）紧密合作，为每位患者配备一名拥有实际出血性疾病管理经验的单一联系人，并提供全天候待命的专业指导支持。

Qfitlia is available today through LUX Infusion. Patients or providers interested in getting therapy started can do so by completing the form at

Qfitlia 现已通过 LUX Infusion 提供。有意开始治疗的患者或医疗服务提供者可通过填写以下表格启动治疗：

luxinfusion.com/get-started/

luxinfusion.com/开始使用/

。

About LUX Infusion

关于 LUX Infusion

LUX Infusion is a U.S.-based, clinician-led infusion services company focused on delivering high-quality, coordinated care for patients who rely on complex infusion therapies. Built around a commitment to clinical expertise, clarity, and elevated patient experiences, LUX Infusion supports patients, providers, payors, and manufacturer partners across a growing national network..

LUX Infusion 是一家总部位于美国、由临床医生主导的输液服务公司，专注于为依赖复杂输液疗法的患者提供高质量、协调一致的护理服务。秉承对临床专业知识、透明度和卓越患者体验的承诺，LUX Infusion 通过不断扩大的全国网络，为患者、医疗服务提供者、支付方以及制药制造商合作伙伴提供支持。

LUX Infusion is a portfolio company of Frazier Healthcare Partners. To learn more, visit

LUX Infusion 是 Frazier Healthcare Partners 旗下的投资组合公司。欲了解更多信息，请访问

www.luxinfusion.com

and follow the company on

并在以下平台关注该公司

Facebook

and

和

领英

。

Media Contact: